143 related articles for article (PubMed ID: 6259294)
1. Adenosine and cyclic AMP in rat cerebral cortical slices: effects of adenosine uptake inhibitors and adenosine deaminase inhibitors.
Nimit Y; Skolnick P; Daly JW
J Neurochem; 1981 Mar; 36(3):908-12. PubMed ID: 6259294
[TBL] [Abstract][Full Text] [Related]
2. Transport of deoxycoformycin in human erythrocytes. Measurement by adenosine deaminase titration and radioisotope assays.
Chen SF; Stoeckler JD; Parks RE
Biochem Pharmacol; 1984 Dec; 33(24):4069-79. PubMed ID: 6334522
[TBL] [Abstract][Full Text] [Related]
3. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
[No Abstract] [Full Text] [Related]
4. Cyclic AMP-generating systems in cell-free preparations from guinea pig cerebral cortex: loss of adenosine and amine responsiveness due to low levels of endogenous adenosine.
McNeal ET; Creveling CR; Daly JW
J Neurochem; 1980 Aug; 35(2):338-42. PubMed ID: 6256482
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 2'-deoxycoformycin, an inhibitor of adenosine deaminase, in the rat.
Geiger JD; Lewis JL; MacIntyre CJ; Nagy JI
Neuropharmacology; 1987 Sep; 26(9):1383-7. PubMed ID: 3499581
[TBL] [Abstract][Full Text] [Related]
6. Degradation of adenosine by extracellular adenosine deaminase in the rat duodenum.
Franco R; Hoyle CH; Centelles JJ; Burnstock G
Gen Pharmacol; 1988; 19(5):679-81. PubMed ID: 3265122
[TBL] [Abstract][Full Text] [Related]
7. The biochemical pharmacology of (2'-R)-chloropentostatin, a novel inhibitor of adenosine deaminase.
Jackson RC; Leopold WR; Ross DA
Adv Enzyme Regul; 1986; 25():125-39. PubMed ID: 2433905
[TBL] [Abstract][Full Text] [Related]
8. Glutamate- and veratridine-elicited accumulations of cyclic AMP in brain slices: a role for factors which potentiate adenosine-responsive systems.
Bruns RF; Pons F; Daly JW
Brain Res; 1980 May; 189(2):550-5. PubMed ID: 6245768
[No Abstract] [Full Text] [Related]
9. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
Smith CM; Belch A; Henderson JF
Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
[No Abstract] [Full Text] [Related]
10. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
Agarwal RP
Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
[No Abstract] [Full Text] [Related]
11. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
Holland MJ
Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):311-24. PubMed ID: 3486439
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of adenosine 3',5'-monophosphate formation in rat cerebral cortical slices by methoxamine: interaction with an alpha adrenergic receptor.
Skolnick P; Daly JW
J Pharmacol Exp Ther; 1975 May; 193(2):549-58. PubMed ID: 238025
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of antiaggregating activity of adenosine by a phosphodiesterase inhibitor, EG626 (oxagrelate), in human platelets in vitro.
Azuma H; Takashima Y; Ishikawa M; Yamakado T
Jpn J Pharmacol; 1984 Feb; 34(2):159-70. PubMed ID: 6205194
[TBL] [Abstract][Full Text] [Related]
14. The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.
Smyth JF; Paine RM; Jackman AL; Harrap KR; Chassin MM; Adamson RH; Johns DG
Cancer Chemother Pharmacol; 1980; 5(2):93-101. PubMed ID: 6970630
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Mitchell BS; Koller CA; Kelley WN
Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
[No Abstract] [Full Text] [Related]
16. Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase.
Szentmiklósi AJ; Németh M; Cseppentö A; Szegi J; Papp JG; Szekeres L
Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):236-52. PubMed ID: 7103613
[TBL] [Abstract][Full Text] [Related]
17. Effects of pentostatin (2'deoxycoformycin), an inhibitor of adenosine deaminase, on type II collagen-induced arthritis in rats.
Gilbertsen RB
J Immunopharmacol; 1985; 7(3):325-41. PubMed ID: 3877119
[TBL] [Abstract][Full Text] [Related]
18. Measurement of adenosine metabolism and uptake in smooth muscle and effects of adenosine transport inhibitors.
Baer HP; Vriend R
J Pharmacol Exp Ther; 1984 May; 229(2):564-70. PubMed ID: 6609231
[TBL] [Abstract][Full Text] [Related]
19. An enzymatic kinetic method for the determination of 2'-deoxycoformycin in biological fluids.
Staubus AE; Weinrib AB; Malspeis L
Biochem Pharmacol; 1984 May; 33(10):1633-7. PubMed ID: 6610419
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of adenosine deaminase leads to enhanced antibody responses in the mouse.
Nicholson JK; Gordon DS; McDougal JS
Cell Immunol; 1983 Jul; 79(2):320-33. PubMed ID: 6347398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
